Lumos Pharma Inc. – Plans of Reorganization, Merger, Acquisition or Similar – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 25 pages Contingent Value Right Agreement

from 8-K 81 pages Agreement and Plan of Merger Among Dpv Parent, Inc., Dpv Mergersub, Inc. and Lumos Pharma, Inc. Dated as of October 22, 2024

from 8-K 3 pages Amendment No. 1 to Agreement and Plan of Merger and Reorganization

from DEFA14A 3 pages Amendment No. 1 to Agreement and Plan of Merger and Reorganization

from 8-K 10 pages Support Agreement

from DEFA14A 10 pages Support Agreement

from DEFA14A 34 pages Agreement and Plan of Merger and Reorganization Among: Newlink Genetics Corporation, a Delaware Corporation; Cyclone Merger Sub, Inc., a Delaware Corporation; and Lumos Pharma, Inc., a Delaware Corporation Dated as of September 30, 2019

from 8-K 34 pages Agreement and Plan of Merger and Reorganization Among: Newlink Genetics Corporation, a Delaware Corporation; Cyclone Merger Sub, Inc., a Delaware Corporation; and Lumos Pharma, Inc., a Delaware Corporation Dated as of September 30, 2019

from 8-K 16 pages Asset Purchase Agreement

from 10-K 2 pages Certification

from 8-K 1 page Newlink Enters Into an Agreement Converting Its $6 Million Forgivable Loan to a Royalty Interest

from 8-K ~5 pages 2012 Target Bonus Awards